S006 Vitiligo
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Recent discoveries in the pathogenesis, risk factors, and features of disease activity have influenced the way that we diagnose and manage vitiligo patients. Clinical trial results for vitiligo are exciting, and we are now prescribing the first FDA-approved medication for the disease. We will discuss patterns of depigmentation, as well as their differential diagnoses and implications for prognosis and treatment. Current approaches to management and their comparative efficacy will be outlined, and emerging targeted therapies will be characterized. The goal is to empower attendees to approach vitiligo in a way that will lead to improved outcomes for their patients.
LEARNING OBJECTIVES
Recognize a variety of presentations of vitiligo in both children and adults, as well as their implications for prognosis and treatment
Describe current therapies, their relative efficacy, and limitations
Discuss emerging treatments in the context of disease pathogenesis, as well as recent clinical trial results
SCHEDULE
2:00 PM
Introduction
John Harris, MD, PhD, FAAD
2:05 PM
The patient perspective
Richard Harold Huggins, MD, FAAD
2:15 PM
Common, uncommon, and rare presentations of vitiligo
Khaled Ezzedine, MD, PhD, IFAAD
2:30 PM
Vitiligo workup and differential diagnosis
Richard Harold Huggins, MD, FAAD
2:45 PM
Chemicals that induce vitiligo: hazard and treatment
Seemal R. Desai, MD, FAAD
3:00 PM
Special considerations in children with vitiligo
Pearl E. Grimes, MD, FAAD
3:15 PM
Questions
Seemal R. Desai, MD, FAAD, Khaled Ezzedine, MD, PhD, IFAAD, Pearl E. Grimes, MD, FAAD, Richard Harold Huggins, MD, FAAD
3:30 PM
Medical therapy for vitiligo
Thierry Passeron, MD, PhD
3:45 PM
Phototherapy for vitiligo
Amit G. Pandya, MD, FAAD
4:00 PM
Surgical therapy for vitiligo
Iltefat H. Hamzavi, MD, FAAD
4:15 PM
Diet and supplements for vitiligo
Nada Elbuluk, MD, FAAD
4:30 PM
Emerging vitiligo treatments
John Harris, MD, PhD, FAAD
4:45 PM
Questions
John Harris, MD, PhD, FAAD, Nada Elbuluk, MD, FAAD, Iltefat H. Hamzavi, MD, FAAD, Amit G. Pandya, MD, FAAD, Thierry Passeron, MD, PhD
SPEAKERS
Seemal R. Desai, MD, FAAD
Nada Elbuluk, MD, FAAD
Khaled Ezzedine, MD, PhD, IFAAD
Pearl E. Grimes, MD, FAAD
Iltefat H. Hamzavi, MD, FAAD
John Harris, MD, PhD, FAAD
Richard Harold Huggins, MD, FAAD
Amit G. Pandya, MD, FAAD
Thierry Passeron, MD, PhD
Mira Walker
HANDOUTS
SPEAKER DISCLOSURES
Seemal R. Desai, MD, FAAD
AbbVie – Consultant(Fees), Speaker(Fees); Allergan, Inc – Consultant(Fees); Amgen – Consultant(Fees); Apogee Therapeutics – Consultant(Fees); Atacama Therapeutics – Investigator(Grants/Research Funding); Avita – Consultant(Fees); Ballature Beauty – Consultant(Fees); Beiersdorf, Inc. – Consultant(Fees); Bristol-Myers Squibb – Consultant(Fees); Candela Corporation – Consultant(Fees); Cassiopea S.p.A. – Consultant(Fees); Castle Biosciences – Consultant(Fees); Cutera, Inc. – Consultant(Fees); Dermavant Sciences, Inc. – Consultant(Fees), Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant(Fees); Ferndale Laboratories, Inc. – Consultant(Honoraria); Foamix – Consultant(Fees); Foundation for Research & Education of Dermatology – Advisory Board(Fees); Galderma Laboratories, LP – Consultant(Fees), Speaker(Honoraria); Global Vitiligo Foundation – Board of Directors(No Compensation Received); Gore Range Capital – Consultant(Stock Options), Stockholder(Stock Options); Hyphens Pharma – Consultant(Fees); Illuminate Skin Care LLC – Founder(Other Financial Benefit); Incyte Corporation – Consultant(Fees), Investigator(Grants/Research Funding); International Society of Dermatology – Board of Directors(No Compensation Received); Janssen Pharmaceuticals, Inc – Consultant(Fees); Johnson and Johnson – Consultant(Fees); L'Oreal USA Inc. – Consultant(Fees); Leo Pharma Inc. – Consultant(Fees); Lyceum Health – Consultant(Fees); Medscape – Other(Fees); National Psoriasis Foundation – Other(No Compensation Received); Ortho Dermatologics – Consultant(Fees); PDH Holdings LLC – Other(No Compensation Received); Pfizer Inc. – Consultant(Fees), Speaker(Honoraria); Revision Skincare – Consultant(Fees); Sanofi/Regeneron – Consultant(Fees); Scientis – Consultant(Fees); Skin Science Advisors – Consultant(Fees); SkinMedica, Inc. – Investigator(Grants/Research Funding); UCB – Consultant(Fees); Verrica Pharmaceuticals Inc – Consultant(Fees); VYNE Therapeutics – Consultant(Fees); Womens Derm Society – Board of Directors(No Compensation Received);
Nada Elbuluk, MD, FAAD
AbbVie – Advisory Board(Fees), Consultant (1099 relationship)(Fees); Avita Medical – Consultant (1099 relationship)(Fees); Beiersdorf – Advisory Board(Fees), Consultant (1099 relationship)(Fees), Speaker(Fees); Canfield Scientific, Inc. – Consultant (1099 relationship)(Fees); Dior – Consultant (1099 relationship)(Fees); Eli Lilly and Company – Advisory Board(Fees); Galderma Laboratories, L.P. – Advisory Board(Fees); Global Vitiligo Foundation – Board of Directors(No Compensation Received); Incyte Corporation – Advisory Board(Fees), Consultant(Fees); Janssen Biotech – Advisory Board(Fees), Consultant (1099 relationship)(Fees); Kao USA – Consultant (1099 relationship)(Fees); Kenvue – Consultant (1099 relationship)(Fees); L'Oreal USA Inc. – Advisory Board(Fees); La Roche-Posay Laboratorie Pharmaceutique – Advisory Board(Fees); McGraw-Hill Companies – Advisory Board(Fees), Other(Other Financial Benefit); Medscape – Speaker(Fees); Pfizer Inc. – Advisory Board(Fees), Investigator(Grants/Research Funding); Sanofi – Advisory Board(Fees); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); VisualDx – Consultant(Fees), Consultant(Stock Options); Women's Dermatologic Society – Board of Directors(No Compensation Received);
Khaled Ezzedine, MD, PhD, IFAAD
AbbVie – Advisory Board(Fees); BMS – Speaker(Honoraria); Eli Lilly – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Fees); Pierre Fabre Dermatologie – Speaker(Honoraria);
Pearl E. Grimes, MD, FAAD
AbbVie – Consultant(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); L'Oreal USA Inc. – Consultant(Grants/Research Funding); Laseroptek USA – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Procter & Gamble Company – Consultant(Honoraria); Scientis – Consultant (1099 relationship)(Honoraria); SkinBetter Science – Investigator(Grants/Research Funding); Versicolor Technologies – Consultant (1099 relationship)(Honoraria), Stockholder Private Company(Honoraria);
Iltefat H. Hamzavi, MD, FAAD
AbbVie – Advisory Board(Fees); Almirall – Consultant (1099 relationship)(Fees); Avita – Investigator(Grants/Research Funding); Beiersdorf, Inc. – Advisory Board(Fees); Boehringer Ingelheim – Consultant(Fees); Clinuvel – Investigator(Fees); Galderma Laboratories, L.P. – Investigator(Fees); Global Vitiligo Foundation – Board of Directors(No Compensation Received); Hidradenitis Suppurativa Foundation – Board of Directors(No Compensation Received); Incyte Corporation – Investigator(Grants/Research Funding); Janssen Biotech – Investigator(Grants/Research Funding); L'Oreal USA Inc. – Investigator(Grants/Research Funding); Lenicura – Investigator(Equipment); MyDerm Portal, Inc – Stockholder(Stock); Novartis – Consultant(Fees); Pfizer Inc. – Investigator(Fees); Sonoma Biotherapeutics – Investigator(Grants/Research Funding); Teva Pharmaceutical Industries Ltd. – Investigator(Fees); UCB – Consultant(Fees); Union Therapeutics – Consultant(Fees); Vimela – Consultant (1099 relationship)(Fees);
John Harris, MD, PhD, FAAD
AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding); Aclaris Therapeutics Inc. – Investigator(Grants/Research Funding); Aclaris Therapeutics, Inc. – Consultant(Fees); Aldena Therapeutics – Consultant(Fees), Founder(Stock); Almirall – Consultant(Fees); Alys Pharmaceuticals – Founder(Salary), Stockholder Private Company(Fees); Bain Capital – Consultant (1099 relationship)(Fees); Barinthus Biotherapeutics North America, Inc. – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant (1099 relationship)(Fees); Boxer Capital Management, LLC – Consultant (1099 relationship)(Fees); Cour Pharmaceuticals – Investigator(Grants/Research Funding); Dren Bio – Investigator(Grants/Research Funding); Granular Therapeutics – Consultant(Fees); Incyte Corporation – Investigator(Grants/Research Funding); Klirna Biotech, Inc. – Founder(Stock); Klirna Therapeutics – Founder(Stock); Leo Pharma Inc – Investigator(Grants/Research Funding); NexImmune – Investigator(Grants/Research Funding); Nira Biosciences, Inc. – Consultant(Fees), Founder(Stock); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Villaris Therapeutics, Inc – Founder(Stock), Investigator(Grants/Research Funding); Vimela – Consultant(Honoraria), Stockholder(Stock); Vividion Therapeutics – Consultant (1099 relationship)(Fees);
Richard Harold Huggins, MD, FAAD
Avita Medical, Inc. – Advisory Board(Fees); Dermsquared – Speaker(Honoraria); Incyte Corporation – Advisory Board(Honoraria); Techspert – Consultant (1099 relationship)(Honoraria);
Amit G. Pandya, MD, FAAD
AbbVie – Consultant(Honoraria); Avita – Consultant(Honoraria); Boehringer Ingelheim – Consultant (1099 relationship)(Honoraria); Immune Tolerance Network – Consultant(Honoraria); Incyte Corporation – Consultant(Honoraria); Pfizer Inc. – Consultant(Honoraria); Tara Medical Devices – Stockholder(Stock); Trifecta Clinical – Consultant(Honoraria); Villaris Therapeutics, Inc – Consultant(Honoraria); VYNE Therapeutics – Consultant(Honoraria); Zerigo Health – Stockholder(Stock);
Thierry Passeron, MD, PhD
AbbVie – Advisory Board(Honoraria), Speaker/Faculty Education(Honoraria); Almirall – Advisory Board(Honoraria); Amgen – Consultant(Honoraria); Astellas Pharma US, Inc – Investigator(Grants/Research Funding); Beiersdorf, Inc. – Speaker(Honoraria); Bioderma – Speaker/Faculty Education(Honoraria); Celgene Corporation – Investigator(Grants/Research Funding); Cutera, Inc. – Advisory Board(Honoraria); Galderma Research & Development, LLC – Advisory Board(Honoraria); GlaxoSmithKline – Speaker/Faculty Education(Honoraria); Hyphens Pharma – Speaker/Faculty Education(Honoraria); Incyte Corporation – Investigator(Fees), Speaker/Faculty Education(Honoraria); ISDIN – Advisory Board(Honoraria), Speaker(Honoraria); Janssen-Cilag – Advisory Board(Honoraria), Speaker/Faculty Education(Honoraria); Journal of the European Academy of Dermatology and Venereology – Other(No Compensation Received); L'Oréal Research and Innovation – Speaker/Faculty Education(Honoraria); La Roche-Posay Laboratorie Pharmaceutique – Speaker/Faculty Education(Honoraria); Leo Pharma Inc. – Speaker/Faculty Education(Honoraria); Lilly ICOS LLC – Speaker/Faculty Education(Honoraria); Mesoestetic USA Laboratories – Advisory Board(Honoraria); MSD – Advisory Board(Honoraria); Novartis – Advisory Board(Honoraria), Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Speaker/Faculty Education(Honoraria); Symrise – Advisory Board(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); Vichy Laboratoires – Advisory Board(Honoraria), Speaker(Honoraria); VYNE Therapeutics – Advisory Board(Honoraria);
Mira Walker
No financial relationships exist with ineligible companies.